^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
GLR2007
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Gan & Lee Pharma
Drug class:
CDK4/6 inhibitor
Related drugs:
Phase 1b/2
Gan and Lee Pharmaceuticals, USA
Completed
Last update posted :
12/23/2022
Initiation :
07/15/2020
Primary completion :
07/29/2022
Completion :
07/29/2022
EGFR • BRAF • ALK • ROS1 • NTRK1 • NTRK
|
GLR2007
Share
